A significant increase was observed in highly differentiated CD57+ NKCD56Dim and NKCD56Bright subpopulations and in the adaptive NK cell population in moderate/severe group (Figure 4C/D), although they were not significantly increased in COVID19 patients who died. This evidence concerns the gene B3GAT1 and COVID-19.